Cargando…
P19-45. Development of a therapeutic HIV vaccine comprised of autologous dendritic cells loaded with a mixture of lipopeptide HIV antigens
Autores principales: | Cobb, AJ, Mead, H, Montes, M, Ranganathan, R, Burkeholder, S, Perry-Finholt, J, Palucka, AK, King, B, Sloan, L, Levy, Y, Roberts, LK, Banchereau, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767876/ http://dx.doi.org/10.1186/1742-4690-6-S3-P365 |
Ejemplares similares
-
Vaccination with dendritic cells loaded with HIV-1 lipopeptides elicits broad T cell immunity and control of viral load in HIV infected patients
por: Levy, Y, et al.
Publicado: (2012) -
P18-11. DALIA: dendritic cell and lipopeptide-induced immunity against AIDS: a phase I trial
por: Banchereau, J, et al.
Publicado: (2009) -
Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination
por: Surenaud, Mathieu, et al.
Publicado: (2019) -
S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies
por: Loof, N, et al.
Publicado: (2009) -
P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
por: Flamar, A, et al.
Publicado: (2009)